Memantine
Memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the Alzheimer’s type. Memantine hydrochloride tablets are an N-methyl-D-aspartate (NMDA) receptor antagonist indicated for the treatment of moderate to severe dementia of the Alzheimer’s type.
United States
$12
per month
India
$1
per month
You save
−94%save $11/mo · 94% cheaper
6.3M US scripts/yr$71.2M potential annual savings$76M US spend/yr
Drag to rotate · 3D structureC12H21N
SMILES: CC12CC3CC(C1)(CC(C3)(C2)N)C
Compare the price
US price$12per month
India price$1per month
You save$1194% less
Based on 30 units per month. US $0.40 vs India $0.03 per unit.
Total over 1 periodSave $11$12 → $1
The bigger picture
Memantine is filled about 6.3M times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$76M
If sourced from India
$4.7M
Potential annual savings
$71.2M
−94%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.